First CRISPR Gene Editing Therapy Nears FDA Approval for Sickle Cell Disease Treatment First CRISPR Gene Editing Therapy Nears FDA...
FDA
2023 Q3: Inventory of Innovative Drugs Approved by NMPA and FDA 2023 Q3: Inventory of Innovative Drugs Approved by NMPA...
FDA's First Potential TIL Therapy Review Delayed: How to Understand FDA's "Resource Constraints"? FDA's First Potential TIL Therapy Review Delayed:...
16 new cancer drugs approved by FDA in the first half of 2023 16 new cancer drugs approved by...
Pfizer and GlaxoSmithKline RSV Vaccine Receives Limited Support from US CDC Experts Pfizer and GlaxoSmithKline RSV Vaccine Receives Limited...
The "magic drug" metformin may make people live to 120 years old! The world's first "elixir of life" came...
FDA approves first re-dose gene therapy: $630000 a year FDA approves first re-dose gene therapy: $630000 a year. On...
FDA Questions Efficacy and Safety of DMD Gene Therapy SRP-9001 FDA Questions Efficacy and Safety of DMD Gene Therapy...
Merck BTK inhibitor was suspended by FDA on Phase III trials Merck BTK inhibitor was suspended by FDA on...
FDA Advisory Committee Meeting on the first DMD gene therapy SRP-9001 is set for May 12th FDA Advisory Committee...
Daybue: First and only FDA approved drug for Rett syndrome Daybue: First and only FDA approved drug for Rett syndrome,...
FDA delays 3-month update on Roktavian gene therapy for hemophilia A. Just when BioMarin considered its hemophilia A gene...
FDA approved 5 new drugs In February: 4 of which were orphan drugs FDA approved 5 new drugs In...
Milestone: FDA approves first human clinical trial of LNP-delivered in vivo CRISPR gene editing Milestone: FDA approves first human...
Musk Neuralink: Application of human trial is rejected by FDA due to big safety risk Musk Neuralink: Application of...
FDA approved the long-acting Altuviiiio therapy for the treatment of hemophilia A FDA approved the long-acting Altuviiiio therapy for...
